- Home
- PGY vs WGS Comparison
PGY vs WGS Comparison
Compare PGY & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGY
- WGS
- Stock Information
- Founded
- PGY 2016
- WGS 2017
- Country
- PGY United States
- WGS United States
- Employees
- PGY N/A
- WGS N/A
- Industry
- PGY Finance: Consumer Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- PGY Finance
- WGS Technology
- Exchange
- PGY Nasdaq
- WGS Nasdaq
- Market Cap
- PGY 2.4B
- WGS 2.4B
- IPO Year
- PGY N/A
- WGS N/A
- Fundamental
- Price
- PGY $33.30
- WGS $126.36
- Analyst Decision
- PGY Strong Buy
- WGS Strong Buy
- Analyst Count
- PGY 9
- WGS 7
- Target Price
- PGY $34.44
- WGS $99.29
- AVG Volume (30 Days)
- PGY 4.0M
- WGS 999.1K
- Earning Date
- PGY 08-07-2025
- WGS 07-29-2025
- Dividend Yield
- PGY N/A
- WGS N/A
- EPS Growth
- PGY N/A
- WGS N/A
- EPS
- PGY N/A
- WGS 0.05
- Revenue
- PGY $1,153,015,000.00
- WGS $362,321,000.00
- Revenue This Year
- PGY $23.03
- WGS $22.16
- Revenue Next Year
- PGY $15.51
- WGS $19.63
- P/E Ratio
- PGY N/A
- WGS $2,607.35
- Revenue Growth
- PGY 24.59
- WGS 48.70
- 52 Week Low
- PGY $8.20
- WGS $28.86
- 52 Week High
- PGY $41.48
- WGS $127.36
- Technical
- Relative Strength Index (RSI)
- PGY 63.07
- WGS 80.63
- Support Level
- PGY $31.24
- WGS $102.97
- Resistance Level
- PGY $34.36
- WGS $108.92
- Average True Range (ATR)
- PGY 3.29
- WGS 7.24
- MACD
- PGY -0.11
- WGS 2.38
- Stochastic Oscillator
- PGY 40.85
- WGS 97.55
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.